Image de couverture de livre

Targeting the DNA damage response in cancer

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Federica Guffanti, Michela Chiappa, Giovanna Damia
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	MedComm
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair
par: Hongjin Qu, et autres
Publié: (2024)

The SUMOylated RREB1 interacts with KDM1A to induce 5‐fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer
par: Ya‐Nan Deng, et autres
Publié: (2025)

Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity
par: Wei Li, et autres
Publié: (2024)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
par: Changping Deng, et autres
Publié: (2025)

Dual Targeting of DNA and EGFR by ZYH005 Induces DNA Damage and Mitotic Catastrophe in Glioblastoma
par: Jianzheng Huang, et autres
Publié: (2026)

Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy
par: Ram Abou Zaki, et autres
Publié: (2025)

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1
par: Yalei Wen, et autres
Publié: (2025)

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
par: Lin‐Zhu Zhang, et autres
Publié: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
par: Shiqi Li, et autres
Publié: (2024)

The Systematic Comparison of Enhancer of Zeste Homolog‐2‐, Bromodomain‐containing Proteins‐, Histone Deacetylase‐, and DNA‐methyltransferase 1‐inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti‐tumoral and Immunomodulatory Activities
par: Valentina Rigo, et autres
Publié: (2025)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
par: Zheng Liu, et autres
Publié: (2025)

Targeting RNA‐binding motif protein 39 for arginine reduction: unveiling metabolic vulnerability in arginine‐dependent liver cancer
par: Aoxue Li, et autres
Publié: (2024)

Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
par: Yuqing Zhao, et autres
Publié: (2024)

Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
par: Jiangchun Wu, et autres
Publié: (2024)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
par: Yalun Li, et autres
Publié: (2024)

Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
par: Yaqing Liu, et autres
Publié: (2025)

Differential expression of the MYC‐Notch axis drives divergent responses to the front‐line therapy in central and peripheral extensive‐stage small‐cell lung cancer
par: Libo Luo, et autres
Publié: (2025)

Melanoma: Pathogenesis and Targeted Therapy
par: Yang Fu, et autres
Publié: (2026)

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
par: Hao Wang, et autres
Publié: (2024)

The multifaceted functions of DNA‐PKcs: implications for the therapy of human diseases
par: Jinghong Wu, et autres
Publié: (2024)

Targeting the Ubiquitin–Proteasome System for Cancer
par: Zhaoyun Liu, et autres
Publié: (2025)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
par: TingDan Hu, et autres
Publié: (2024)

The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
par: Jian Tang, et autres
Publié: (2024)

Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
par: Xishan Yang, et autres
Publié: (2026)

RNA modifications in cancer
par: Han Wu, et autres
Publié: (2025)

Circular RNAs in cancer
par: Yang Guo, et autres
Publié: (2025)

Redefining DNA cleavage in type I CRISPR systems with the HNH domain
par: Senfeng Zhang, et autres
Publié: (2025)

Progress in Natural Products Target Discovery Technology
par: Qiyuan Pan, et autres
Publié: (2026)

Targeting KRAS in Cancer Therapy: Beyond Inhibitors
par: Chunhui Chen, et autres
Publié: (2025)

Progress in RNA‐Targeted Therapeutics for Human Diseases
par: Wangzheqi Zhang, et autres
Publié: (2026)

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets
par: Xiaoshuang Song, et autres
Publié: (2025)

Breast Cancer: Molecular Pathogenesis and Targeted Therapy
par: Md Abdus Samad, et autres
Publié: (2025)

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets
par: Qianying Ouyang, et autres
Publié: (2026)

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets
par: Xiaodie Liu, et autres
Publié: (2026)

Biomedical applications of stimuli‐responsive nanomaterials
par: Xiaojie Chen, et autres
Publié: (2024)

Targeting esophageal carcinoma: molecular mechanisms and clinical studies
par: Wenjing Wang, et autres
Publié: (2024)

Neutrophil extracellular traps in cancer
par: Yuxi Ma, et autres
Publié: (2024)

Immunoglobulin A Nephropathy: Molecular Pathogenesis and Targeted Therapy
par: Xu‐Jie Zhou
Publié: (2025)

Epigenetic Regulation in Cardiovascular Diseases: Mechanisms and Therapeutic Targets
par: Wangzheqi Zhang, et autres
Publié: (2026)

Oxidative Stress: Molecular Mechanisms, Diseases, and Therapeutic Targets
par: Yi Qin, et autres
Publié: (2026)